A model to determine colorectal cancer risk using common genetic susceptibility loci
- PMID: 25683114
- PMCID: PMC4446193
- DOI: 10.1053/j.gastro.2015.02.010
A model to determine colorectal cancer risk using common genetic susceptibility loci
Abstract
Background & aims: Risk for colorectal cancer (CRC) can be greatly reduced through screening. To aid in the development of screening strategies, we refined models designed to determine risk of CRC by incorporating information from common genetic susceptibility loci.
Methods: By using data collected from more than 12,000 participants in 6 studies performed from 1990 through 2011 in the United States and Germany, we developed risk determination models based on sex, age, family history, genetic risk score (number of risk alleles carried at 27 validated common CRC susceptibility loci), and history of endoscopic examinations. The model was validated using data collected from approximately 1800 participants in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial, conducted from 1993 through 2001 in the United States.
Results: We identified a CRC genetic risk score that independently predicted which patients in the training set would develop CRC. Compared with determination of risk based only on family history, adding the genetic risk score increased the discriminatory accuracy from 0.51 to 0.59 (P = .0028) for men and from 0.52 to 0.56 (P = .14) for women. We calculated age- and sex-specific 10-year CRC absolute risk estimates based on the number of risk alleles, family history, and history of endoscopic examinations. A model that included a genetic risk score better determined the recommended starting age for screening in subjects with and without family histories of CRC. The starting age for high-risk men (family history of CRC and genetic risk score, 90%) was 42 years, and for low-risk men (no family history of CRC and genetic risk score, 10%) was 52 years. For men with no family history and a high genetic risk score (90%), the starting age would be 47 years; this is an intermediate value that is 5 years earlier than it would be for men with a genetic risk score of 10%. Similar trends were observed in women.
Conclusions: By incorporating information on CRC risk alleles, we created a model to determine the risk for CRC more accurately. This model might be used to develop screening and prevention strategies.
Keywords: Colorectal Cancer Screening; Genome-Wide Association Study; Risk Determination; Risk Stratification.
Copyright © 2015 AGA Institute. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Figures

Comment in
-
Machine Learning Methods in Gastroenterology.Gastroenterology. 2015 Oct;149(4):1128-9. doi: 10.1053/j.gastro.2015.03.056. Epub 2015 Aug 28. Gastroenterology. 2015. PMID: 26319037 No abstract available.
-
Reply: To PMID 25683114.Gastroenterology. 2015 Oct;149(4):1129. doi: 10.1053/j.gastro.2015.08.021. Epub 2015 Aug 28. Gastroenterology. 2015. PMID: 26319039 No abstract available.
Similar articles
-
Determining Risk of Colorectal Cancer and Starting Age of Screening Based on Lifestyle, Environmental, and Genetic Factors.Gastroenterology. 2018 Jun;154(8):2152-2164.e19. doi: 10.1053/j.gastro.2018.02.021. Epub 2018 Feb 17. Gastroenterology. 2018. PMID: 29458155 Free PMC article.
-
Estimation of Absolute Risk of Colorectal Cancer Based on Healthy Lifestyle, Genetic Risk, and Colonoscopy Status in a Population-Based Study.Gastroenterology. 2020 Jul;159(1):129-138.e9. doi: 10.1053/j.gastro.2020.03.016. Epub 2020 Mar 14. Gastroenterology. 2020. PMID: 32179093 Free PMC article.
-
Susceptibility genetic variants associated with colorectal cancer risk correlate with cancer phenotype.Gastroenterology. 2010 Sep;139(3):788-96, 796.e1-6. doi: 10.1053/j.gastro.2010.05.072. Epub 2010 Jun 2. Gastroenterology. 2010. PMID: 20638935
-
Genetic predisposition to colorectal cancer: where we stand and future perspectives.World J Gastroenterol. 2014 Aug 7;20(29):9828-49. doi: 10.3748/wjg.v20.i29.9828. World J Gastroenterol. 2014. PMID: 25110415 Free PMC article. Review.
-
Colorectal Cancer Risk Loci: Prognostic Factors for Clinical Outcomes? A Systematic Review and Meta-Analysis.Cancer Rep (Hoboken). 2025 May;8(5):e70230. doi: 10.1002/cnr2.70230. Cancer Rep (Hoboken). 2025. PMID: 40387276 Review.
Cited by
-
Colorectal Cancer Polygenic Risk Score Is Associated With Screening Colonoscopy Findings but Not Follow-Up Outcomes.Gastro Hep Adv. 2023 Oct 10;3(2):151-161. doi: 10.1016/j.gastha.2023.10.001. eCollection 2024. Gastro Hep Adv. 2023. PMID: 39129957 Free PMC article.
-
Clinically relevant combined effect of polygenic background, rare pathogenic germline variants, and family history on colorectal cancer incidence.BMC Med Genomics. 2023 Mar 5;16(1):42. doi: 10.1186/s12920-023-01469-z. BMC Med Genomics. 2023. PMID: 36872334 Free PMC article.
-
Risk Scores for Predicting Advanced Colorectal Neoplasia in the Average-risk Population: A Systematic Review and Meta-analysis.Am J Gastroenterol. 2018 Dec;113(12):1788-1800. doi: 10.1038/s41395-018-0209-2. Epub 2018 Oct 12. Am J Gastroenterol. 2018. PMID: 30315282 Free PMC article.
-
Risk Model for Colorectal Cancer in Spanish Population Using Environmental and Genetic Factors: Results from the MCC-Spain study.Sci Rep. 2017 Feb 24;7:43263. doi: 10.1038/srep43263. Sci Rep. 2017. PMID: 28233817 Free PMC article.
-
Colorectal Cancer Epidemiology in the Nurses' Health Study.Am J Public Health. 2016 Sep;106(9):1599-607. doi: 10.2105/AJPH.2016.303320. Epub 2016 Jul 26. Am J Public Health. 2016. PMID: 27459444 Free PMC article. Review.
References
-
- Institute NC. Cancer Genetic Markers of Susceptibility (CGEMS) data website. 2009;2013
-
- Yeager M, Orr N, Hayes RB, et al. Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet. 2007;39:645–9. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- U01 HG004438/HG/NHGRI NIH HHS/United States
- R01 AG014358/AG/NIA NIH HHS/United States
- P01 CA087969/CA/NCI NIH HHS/United States
- HHSN268201100046C/HL/NHLBI NIH HHS/United States
- U01 CA164930/CA/NCI NIH HHS/United States
- R01 CA137178/CA/NCI NIH HHS/United States
- HHSN271201100004C/AG/NIA NIH HHS/United States
- R25CA094880/CA/NCI NIH HHS/United States
- HHSN268201100002C/WH/WHI NIH HHS/United States
- UM1 CA167552/CA/NCI NIH HHS/United States
- K05 CA152715/CA/NCI NIH HHS/United States
- HHSN268201100002I/HL/NHLBI NIH HHS/United States
- P50 CA127003/CA/NCI NIH HHS/United States
- HHSN268201100001C/WH/WHI NIH HHS/United States
- HHSN268201100004C/WH/WHI NIH HHS/United States
- U19 CA148107/CA/NCI NIH HHS/United States
- R01 CA059045/CA/NCI NIH HHS/United States
- HHSN268201100001I/HL/NHLBI NIH HHS/United States
- P01 CA 087969/CA/NCI NIH HHS/United States
- U01 HG004446/HG/NHGRI NIH HHS/United States
- HHSN268201100004I/HL/NHLBI NIH HHS/United States
- Z01 CP010200/ImNIH/Intramural NIH HHS/United States
- P01 CA53996/CA/NCI NIH HHS/United States
- P01 CA053996/CA/NCI NIH HHS/United States
- K05 CA154337/CA/NCI NIH HHS/United States
- P01 CA055075/CA/NCI NIH HHS/United States
- P50 CA 127003/CA/NCI NIH HHS/United States
- R01 CA048998/CA/NCI NIH HHS/United States
- R25 CA094880/CA/NCI NIH HHS/United States
- U01 CA137088/CA/NCI NIH HHS/United States
- HHSN268201100003C/WH/WHI NIH HHS/United States
- R01AG14358/AG/NIA NIH HHS/United States
- R01 ES019876/ES/NIEHS NIH HHS/United States
- R01 CA48998/CA/NCI NIH HHS/United States
- U01 CA185094/CA/NCI NIH HHS/United States
- P01 CA 055075/CA/NCI NIH HHS/United States
- U01 HG 004438/HG/NHGRI NIH HHS/United States
- S10 OD020069/OD/NIH HHS/United States
- HHSN268201100003I/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical